Group 1 - The company is focusing on AI and digital transformation as key strategic initiatives to drive growth through the rest of the decade [2] - The MEDITECH Expanse rollout is currently live at nearly 50 hospitals and is expected to be completed by the end of 2028, marking it as the largest project in the company's history in terms of resources, time, and effort [3] - The Expanse system is cloud-native, enabling standardized data management and improved workflow capabilities [3]

Core Insights - Jensen Investment Management's fourth-quarter investor letter for the "Jensen Quality Growth Equity Strategy" indicates that the strategy underperformed the S&P 500 Index in Q4 2025, returning -0.55% compared to the Index's 2.66% [1] - The underperformance was primarily attributed to the Industrials sector and the outperformance of low-quality stocks, highlighting a current market trend characterized by concentration in mega-cap technology [1] - The portfolio is strategically positioned to benefit from growth in AI and digital transformation while focusing on quality and durability for long-term shareholder returns [1] Company-Specific Insights - Amphenol Corporation (NYSE: APH) is highlighted as a key holding, being a leading manufacturer of electrical, electronic, and fiber optic connectors [2] - As of March 06, 2026, Amphenol's stock closed at $131.87, with a one-month return of -8.55% and a significant 52-week gain of 113.42% [2] - The market capitalization of Amphenol Corporation is reported at $162.097 billion [2] - The Quality Growth Investment Team liquidated positions in Amphenol Corporation during the fourth quarter of 2025 [3]

Core Insights - Jensen Investment Management's fourth-quarter investor letter for the "Jensen Quality Growth Equity Strategy" indicates that the strategy underperformed the S&P 500 Index in Q4 2025, returning -0.55% compared to the Index's 2.66% [1] - The underperformance was primarily attributed to the Industrials sector and the outperformance of low-quality stocks, highlighting a current market trend favoring mega-cap technology [1] - The portfolio is strategically positioned to benefit from growth in AI and digital transformation while focusing on quality and durability for long-term shareholder returns [1] Company-Specific Insights - Accenture plc (NYSE:ACN), a professional services and technology services company, was highlighted in the investor letter, with its stock closing at $214.00 on March 05, 2026 [2] - Accenture's one-month return was -11.06%, and it experienced a significant decline of 37.46% over the past 52 weeks, with a market capitalization of $132.71 billion [2] - The Quality Growth Investment Team liquidated positions in Accenture plc during the fourth quarter of 2025, along with Amphenol and Zoetis [3]

Financial Data and Key Metrics Changes - Adjusted earnings per share (EPS) for Q3 2025 was $3.09, exceeding guidance and higher than the previous year, excluding LNG business sales impact [2][6] - Sales volume decreased by 4% year-over-year, primarily due to the sale of the LNG business and lower helium demand [6][7] - Total company price increased by 1%, with a 2% improvement in the merchant business [6][7] - Adjusted operating income remained unchanged, with operating margin flat but improved by approximately 300 basis points sequentially due to favorable volume and productivity improvements [7][8] Business Line Data and Key Metrics Changes - The core industrial gas business showed resilience, with strong performance in non-helium products across all regions [2][7] - Helium EPS contributions were down about 4% versus the prior year, with an anticipated headwind of around 55 to 60 cents for the full year [23] Market Data and Key Metrics Changes - The Americas experienced a 6% decline in volume, primarily due to project exits and lower helium demand, although strong on-site volumes were noted [34][35] - The company expects to see improvements in overall merchant business outside of helium demand [35] Company Strategy and Development Direction - The company aims for high single-digit adjusted EPS growth starting in fiscal year 2026, with a target of achieving operating margins of 30% and return on capital employed (ROCE) in the mid to high teens by 2030 [5][6] - A global cost reduction plan is expected to generate annual savings of $185 to $195 million, with a focus on digital transformation and AI tools to enhance productivity [3][4][30] Management's Comments on Operating Environment and Future Outlook - Management remains cautious about the economic outlook, recognizing significant global uncertainties [10] - The company is optimistic about the competitiveness of its projects, particularly in the blue ammonia market, and is actively seeking partnerships for future projects [15][49] Other Important Information - The fiscal full-year adjusted EPS guidance is maintained at $11.90 to $12.10, with capital expenditures expected to be approximately $5 billion [10] - The company is committed to maintaining capital discipline while pursuing growth opportunities in its core industrial gas business [4][6] Q&A Session Summary Question: Update on the plan to use third parties at Darrow for ammonia and carbon capturing - Management is optimistic about finalizing partnerships by the end of the current year, with competitive CapEx numbers for their projects [14][15] Question: Average prices year-over-year and helium impact - Management indicated that they typically do not disclose specific numbers but acknowledged helium's impact on pricing [18][20] Question: Volume performance in the Americas - The decline was largely due to project exits and helium demand, with strong on-site volumes noted [34][35] Question: Update on larger project announcements in the Gulf Coast - Management believes there is still demand for clean ammonia, particularly in the Far East, and expects competitive positioning for their projects [48][49] Question: Trajectory to achieve long-term ROCE goals - Current ROCE is around 11.1%, with expectations to improve as capital expenditures are reduced and cash balances increase [70][72] Question: Inflation impact on costs - Management continues to see inflation as a concern, with ongoing efforts to manage pricing effectively [76][77] Question: Update on underperforming projects - Projects in Edmonton, Rotterdam, and Arizona are on schedule, with no significant changes expected [80][81]

Core Insights - Calian Group Ltd. has appointed Chris Pogue as President of Defence & Space, effective July 7, 2025, to lead a newly created organization that integrates its Advanced Technologies and Learning business units [1][2] - Pogue brings over 20 years of experience in defence and space innovation, having previously served as President and CEO of Thales Canada and held leadership roles at MDA Government and General Dynamics [2] - The appointment aligns with Calian's One Calian 2026 strategy, enhancing its capability to deliver mission-critical solutions amid growing global demand [3] Company Overview - Calian Group Ltd. focuses on mission-critical solutions in defence, space, healthcare, and strategic growth critical infrastructure sectors [1] - The company has a 40-year history and operates in North American, European, and international markets, emphasizing values such as customer commitment, integrity, innovation, respect, and teamwork [4]